No specific medication or rehabilitation plan has been evaluated in ALS patients with cognitive impairment; however, memantine and cholinesterase inhibitors are usually avoided in the treatment of FTD patients without ALS due to lack of effect (217) or a possible worsening of behavioral symptoms (218). The gene discussed is BCHE; the disease is amyotrophic lateral sclerosis.